Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q218820> ?p ?o }
Showing triples 1 to 71 of
71
with 100 triples per page.
- Q218820 subject Q6403537.
- Q218820 subject Q7108202.
- Q218820 subject Q8707608.
- Q218820 subject Q8873325.
- Q218820 abstract "Zolmitriptan is a selective serotonin receptor agonist of the 1B and 1D subtypes. It is a triptan, used in the acute treatment of migraine attacks with or without aura and cluster headaches.Zolmitriptan is marketed by AstraZeneca with the brand names Zomig, Zomigon (Argentina, Canada & Greece), AscoTop (Germany) and Zomigoro (France). In 2008, Zomig generated nearly $154 million in sales.AstraZeneca's U.S. patent on Zomig tablets expired on November 14, 2012, and its pediatric exclusivity extension expired on May 14, 2013. The patent in certain European countries has already expired too, and generic drug maker Actavis released a generic version in those countries, starting in March 2012.".
- Q218820 atcPrefix "N02".
- Q218820 atcSuffix "CC03".
- Q218820 bioavailability "40.0".
- Q218820 casNumber "139264-17-8".
- Q218820 chEBI "10124".
- Q218820 drugbank "DB00315".
- Q218820 fdaUniiCode "2FS66TH3YW".
- Q218820 iupacName "(S)-4-({3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one".
- Q218820 pubchem "60857".
- Q218820 thumbnail Zolmitriptan_Structure_V.1.svg?width=300.
- Q218820 wikiPageExternalLink www.zomig.com.
- Q218820 wikiPageExternalLink Zomig.pdf.
- Q218820 wikiPageWikiLink Q1077823.
- Q218820 wikiPageWikiLink Q12152.
- Q218820 wikiPageWikiLink Q133823.
- Q218820 wikiPageWikiLink Q1469637.
- Q218820 wikiPageWikiLink Q14890102.
- Q218820 wikiPageWikiLink Q1641556.
- Q218820 wikiPageWikiLink Q166907.
- Q218820 wikiPageWikiLink Q180762.
- Q218820 wikiPageWikiLink Q186889.
- Q218820 wikiPageWikiLink Q194041.
- Q218820 wikiPageWikiLink Q213433.
- Q218820 wikiPageWikiLink Q270421.
- Q218820 wikiPageWikiLink Q343204.
- Q218820 wikiPageWikiLink Q3503092.
- Q218820 wikiPageWikiLink Q409439.
- Q218820 wikiPageWikiLink Q410954.
- Q218820 wikiPageWikiLink Q421336.
- Q218820 wikiPageWikiLink Q423866.
- Q218820 wikiPageWikiLink Q424442.
- Q218820 wikiPageWikiLink Q45959.
- Q218820 wikiPageWikiLink Q474959.
- Q218820 wikiPageWikiLink Q5172199.
- Q218820 wikiPageWikiLink Q623289.
- Q218820 wikiPageWikiLink Q633403.
- Q218820 wikiPageWikiLink Q6403537.
- Q218820 wikiPageWikiLink Q653971.
- Q218820 wikiPageWikiLink Q693058.
- Q218820 wikiPageWikiLink Q7108202.
- Q218820 wikiPageWikiLink Q731938.
- Q218820 wikiPageWikiLink Q739481.
- Q218820 wikiPageWikiLink Q7455050.
- Q218820 wikiPageWikiLink Q769220.
- Q218820 wikiPageWikiLink Q82642.
- Q218820 wikiPageWikiLink Q8707608.
- Q218820 wikiPageWikiLink Q8873325.
- Q218820 wikiPageWikiLink Q9368.
- Q218820 wikiPageWikiLink Q9377.
- Q218820 atcPrefix "N02".
- Q218820 atcSuffix "CC03".
- Q218820 bioavailability "40.0".
- Q218820 casNumber "139264".
- Q218820 chebi "10124".
- Q218820 drugbank "DB00315".
- Q218820 iupacName "-4".
- Q218820 pubchem "60857".
- Q218820 unii "2".
- Q218820 type ChemicalSubstance.
- Q218820 type Drug.
- Q218820 type ChemicalObject.
- Q218820 type Thing.
- Q218820 type Q8386.
- Q218820 comment "Zolmitriptan is a selective serotonin receptor agonist of the 1B and 1D subtypes. It is a triptan, used in the acute treatment of migraine attacks with or without aura and cluster headaches.Zolmitriptan is marketed by AstraZeneca with the brand names Zomig, Zomigon (Argentina, Canada & Greece), AscoTop (Germany) and Zomigoro (France). In 2008, Zomig generated nearly $154 million in sales.AstraZeneca's U.S.".
- Q218820 label "Zolmitriptan".
- Q218820 depiction Zolmitriptan_Structure_V.1.svg.